Publications(FY 2019)

2018-02.

Harada K, Nozawa M, Uemura M, Tatsugami K, Osawa T, Yamana K, Kimura G, Fujisawa M, Nonomura N, Eto M, Shinohara N, Tomita Y, Kondo Y, Ochi K, Anazawa Y, Uemura H.
Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan.
Int J Urol. 2018. doi: 10.1111/iju.13830. [5Y-IF: 2.097]

2018-03.

Hirose T, Hotta K, Iwami D, Harada H, Morita K, Tanabe T, Sasaki H, Fukuzawa N, Seki T, Shinohara N.
Safety and efficacy of retroperitoneoscopic living donor nephrectomy: Comparison of early complication, donor and recipient outcome with hand-assisted laparoscopic living donor nephrectomy.
J Endourol. 2018 doi: 10.1089/end.2018.0669 [5y-IF: 2.035]

2018-04.

Ishikawa M, Tanino MA, Miyazaki M, Kimura T, Ishida Y, Wang L, Tsuda M, Nishihara H, Nagashima K, Tanaka S.
A Clinicopathological Analysis of Six Autopsy Cases of Sudden Unexpected Death due to Infectious Aortitis in Patients with Aortic Tears.
Intern Med. 2018;57(10):1375-1380. [5y-IF: 1.009]

2018-05.

Iwami D, Aramaki O, Shinohara N, Niimi M, Shirasugi N.
Administration of donor splenocytes via the respiratory tract generates CD8α+ regulatory dendritic cells and induces hyporesponsiveness to fully allogeneic cardiac grafts.
Transpl Immunol. 2018;50:60-67. [5y-IF: 1.520]

2018-06.

Iwami D, Miura M, Chiba Y, Ota M, Matsumoto T, Hotta K, Sasaki H, Hirose T, Harada H, Shinohara N.
Optimal settings for double filtration plasmapheresis with targeted removal rate of preexisting antibody in antibody-incompatible kidney transplant.
Transplant Proc. 2018; 50(10):3478-3482. [5y-IF: 0.938]

2018-07.

Iwano H, Tsujinaga S, Iwami D, Asakawa N, Yamada S, Anzai T.
Clinical utility of echocardiographic hemodynamic monitoring during manual compression of arteriovenous shunt in a patient with high-output heart failure.
CASE (Phila). 2018; 2(3):103-108. [5y-IF: ‐]

2018-08.

Nishimura Y, Moriya K, Kobayashi S, Araki A, Sata F, Mitsui T, Itoh S, Miyashita C, Cho K, Kon M, Nakamura M, Kitta T, Murai S, Kishi R, Shinohara N.
Association between ESR1 polymorphisms and second to fourth digit ratio in school-aged children in the Hokkaido Study.
Steroids. 2018. doi: 10.1016/j.steroids.2018.11.011. [5y-IF: 2.557]

2018-09.

Raison N, Ahmed K, Abe T, Brunckhorst O, Novara G, Buffi N, McIlhenny C, van der Poel H, van Hemelrijck M, Gavazzi A, Dasgupta P.
Cognitive training for technical and non-technical skills in robotic surgery: a randomised controlled trial.
BJU Int. 2018; 122(6):1075-1081.

2018-10.

Rivard CJ, Tanabe T, Lanaspa MA, Watanabe H, Nomura S, Andres-Hernando A, Garth K, Sekijima M, Ishimoto T, Ariyoshi Y, Garcia GE, Shah J, Lennan B, Tasaki M, Pomposelli T, Shimizu A, Sachs DH, Johnson RJ, Yamada K.
Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental study.
Transpl Int. 2018; 31(10):1164-1177. [5y-IF: 3.145]

2018-11.

Shima H, Hayashi M, Tachibana T, Oshiro M, Amano N, Ishii T, Haruna H, Igarashi M, Kon M, Fukuzawa R, Tanaka Y, Fukami M, Hasegawa T, Narumi S.
MIRAGE syndrome is a rare cause of 46,XY DSD born SGA without adrenal insufficiency.
PLoS One, 2018; 13(11):e0206184.

2018-12.

Takahashi S, Kinuya S, Nonomura N, Shinohara N, Suzuki K, Suzuki H, Nakamura K, Satoh T, Tateishi U, Yoneda T, Horikoshi H, Igawa T, Kamai T, Koizumi M, Kosaka T, Matsubara N, Miyake H, Mizokami A, Mizowaki T, Nakamura N, Nozawa M, Takahashi T, Uemura H, Uemura M, Yokomizo A, Yoshimura M, Kakehi Y.
Japanese expert panel meeting on the management of prostate cancer with bone metastases.
Oncol Ther. 2018; 6(2):157-171. [5y-IF:－ ]

2018-13.

Watanabe H, Sahara H, Nomura S, Tanabe T, Ekanayake-Alper DK, Boyd LK, Louras NJ, Asfour A, Danton MA, Ho SH, Arn SJ, Hawley RJ, Shimizu A, Nagayasu T, Ayares D, Lorber MI, Sykes M, Sachs DH, Yamada K.
GalT-KO pig lungs are highly susceptible to acute vascular rejection in baboons, which may be mitigated by transgenic expression of hCD47 on porcine blood vessels.
Xenotransplantation, 2018; 25(5):e12391. [5y-IF: 3.513]

2019-01.

Abe T, Minami K, Harabayashi T, Sazawa A, Chiba H, Kikuchi H, Miyata H, Matsumoto R, Osawa T, Maruyama S, Ishizaki J, Mochizuki T, Chiba S, Akino T, Murakumo M, Miyajima N, Tsuchiya K, Murai S, Shinohara N.
Outcome of maintenance systemic chemotherapy with drug-free interval for metastatic urothelial carcinoma.
Jpn J Clin Oncol. 2019. doi: 10.1093/jjco/hyz084. [5y-IF: 2.135]

2019-02.

Abe T, Dar F, Amnattrakul P, Aydin A, Raison N, Shinohara N, Khan MS, Ahmed K, Dasgupta P.
The effect of repeated full immersion simulation training in ureterorenoscopy on mental workload of novice operators.
BMC Med Educ. 2019;19(1):318. [5y-IF: 2.317]

2019-03.

Abe T, Minami K, Harabayashi T, Sazawa A, Chiba H, Kikuchi H, Miyata H, Furumido J, Matsumoto R, Osawa T, Ishizaki J, Mochizuki T, Chiba S, Akino T, Murakumo M, Miyajima N, Tsuchiya K, Maruyama S, Murai S, Shinohara N.
Prognostic impact of local radiotherapy on metastatic urothelial carcinoma patients receiving systemic chemotherapy.
Jpn J Clin Oncol. 2019; doi: 10.1093/jjco/hyz152. [5y-IF: 2.135]

2019-04.

Furumido J, Osawa T, Kikuchi H, Matsumoto R, Abe T, Takakuwa E, Shinohara N.
Retroperitoneal extragonadal germ cell tumor without distant metastasis: a case report.
Int Cancer Conf J. 2019; doi: 10.1007/s13691-019-00384-4. [5y-IF: ‐]

2019-05.

Higuchi M, Kitta T, Kanno Y, Kon M, Nakamura M, Moriya K, Shinohara N.
Bladder dysfunction and urinary tract infection caused by abdominal pseudocyst with a ventriculoperitoneal shunt: A case report with literature review.
Pediatr Urol Case Rep. 2019; 6(5):100-105, 2019. [5y-IF: ‐]

2019-06.

Hirose T, Iwami D, Hotta K, Sasaki H, Higuchi H, Shinohara N.
Percentage of CD19＋ Cells in peripheral blood lymphocytes after rituximab-based desensitization as a predictor of acute antibody-mediated rejection in ABO-Incompatible kidney transplantation.
Transplant Proc. 2019; doi: 10.1016/j.transproceed.2019.01.127. [5y-IF: 1.058]

2019-07.

Hotta K.
Editorial Comment from Dr Hotta to Clinical impact of glomerular basement membrane thickness on post-donation renal function in living donors.
Int J Urol. 2019 Feb; 26(2):311.[5y-IF: 2.034]

2019-08.

Hotta K, Hirose T, Iwami D, Shinohara N.
Response to letter to the editor RE: Goyal et al., safety and efficacy of retroperitoneoscopic living donor nephrectomy: Comparison of early complication, donor and recipient outcome with hand-assisted laparoscopic living donor nephrectomy by Hirose et al. (From: Goyal K, Singh AK, Kumar U, et al. J Endourol 2019 [Epub ahead of print]; DOI: 10.1089/end.2019.0099)
J Endourol. 2019 doi: 10.1089/end.2019.29057.kho.[5y-IF: 2.067]

2019-09.

Ishikawa H, Tsuji H, Murayama S, Sugimoto M, Shinohara N, Maruyama S, Murakami M, Shirato H, Sakurai H.
Particle therapy for prostate cancer: The past, present and future.
Int J Urol. 2019; doi: 10.1111/iju.14041. [5y-IF: 2.034]

2019-10.

Iwami D.
Editorial Comment from Dr Iwami to Clinical impact of glomerular basement membrane thickness on post-donation renal function in living donors.
Int J Urol. 2019 Feb; 26(2):312. [5y-IF: 2.034]

2019-11.

Iwami D, Shinohara N. Anti-ABO Antibody Elimination: Pre- and Post-ABO-Incompatible Kidney Transplantation. In: Wang Y. (eds)
ABO-incompatible Organ Transplantation (eBook).
Springer, Singapore. (2019) [Textbook]

2019-12.

Iwami D, Hotta K, Sasaki H, Hirose T, Higuchi H, Takada Y, Iwahara N, Shinohara N.
A 2-mm Cutoff Value Is Reasonable and Feasible for Vascular Reconstruction in a Kidney Allograft With Multiple Arteries.
Transplant Proc. 2019; doi: 10.1016/j.transproceed.2019.01.137. [5y-IF: 1.058]

2019-13.

Kikuchi H, Abe T, Matsumoto R, Osawa T, Maruyama S, Murai S, Shinohara N.
Nephrometry score correlated with tumor proliferative activity inT1 clear cell renal cell carcinoma.
Urol Oncol. 2019; doi: 10.1016/j.urolonc.2019.02.005. [5y-IF: 2.914]

2019-14.

Kitta T.
Editorial Comment to Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled study.
Int J Urol. 2019; 26(2):200-201. [5y-IF: 2.034]

2019-15.

Kitta T.
Editorial Comment to Efficacy of novel β3 -adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study.
Int J Urol. 2019; 26(3):375-376. [5y-IF: 2.034]

2019-16.

Kitta T.
Editorial Comment to Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study).
Int J Urol. 2019; 26(3):352. [5y-IF: 2.034]

2019-17.

Kume H, Homma Y, Shinohara N, Obara W, Kondo T, Kimura G, Fujimoto H, Nonomura N, Hongo F, Sugiyama T, Takahashi M, Kanayama HO, Fukumori T, Eto M.
Perinephric invasion as a prognostic factor in non-metastatic renal cell carcinoma: analysis of a nation-wide registry program.
Jpn J Clin Oncol. 2019; doi: 10.1093/jjco/hyz054. [5y-IF: 2.135]

2019-18.

Maishi N, Kikuchi H, Sato M, Nagao-Kitamoto H, Annan DA, Baba S, Hojo T, Yanagiya M, Ohba Y, Ishii G, Masutomi K, Shinohara N, Hida Y, Hida K.
Development of Immortalized Human Tumor Endothelial Cells from Renal Cancer.
Int J Mol Sci. 2019; 20(18). doi: 10.3390/ijms20184595[5y-IF: 4.331]

2019-19.

Mikami S, Mizuno R, Kondo T, Shinohara N, Nonomura N, Ozono S, Eto M, Tatsugami K, Takayama T, Matsuyama H, Kishida T, Oya M.
Japanese Society of Renal Cancer：Clinical significance of PD-1 and PD-L1 expression in the tumor microenvironment of clear cell renal cell carcinoma.
Cancer Sci. 2019; doi: 10.1111/cas.14019. [5y-IF: 4.382]

2019-20.

Mitsui T, Araki A, Miyashita C, Ito S, Ikeno T, Sasaki S, Kitta T, Moriya K, Cho K, Morioka K, Kishi R, Shinohara N, Takeda M, Nonomura K.
Effects of prenatal sex hormones on behavioral sexual dimorphism.
Pediatr Int. 2019; 61(2):140-146. [5y-IF: 0.985]

2019-21.

Miyata H, Abe T, Hotta K, Higuchi M, Osawa T, Matsumoto R, Kikuchi H, Kurashima Y, Murai S, Shinohara N.
Validity Assessment of the Laparoscopic Radical Nephrectomy Module of the LapVision® Virtual Reality Simulator.
Surgery Open Science 2019; doi.org/10.1016/j.sopen.2019.08.003

2019-22.

Moriya K, Nakamura M, Kon M, Nishimura Y, Kanno Y, Kitta T, Shinohara N.
Risk factors affecting post-pubertal high serum follicle-stimulating hormone in patients with hypospadias.
World J Urol. 2019; doi: 10.1007/s00345-019-02687-w. [5y-IF: 2.466]

2019-23.

Nakamura M, Moriya K, Kon M, Nishimura Y, Kitta T, Shinohara N.
Laparoscopic nephroureterectomy using the stoma site of cutaneous ureterostomy as a multi-channel port site in a 15-month-old child with megaureter: A case report.
Urol Case Rep. 2019; 27:100990. doi: 10.1016/j.eucr.2019.100990. eCollection 2019 Nov. [5y-IF: ‐]

2019-24.

Nishimura Y, Moriya K, Kobayashi S, Araki A, Sata F, Mitsui T, Itoh S, Miyashita C, Cho K, Kon M, Nakamura M, Kitta T, Murai S, Kishi R, Shinohara N.
Association between ESR1 polymorphisms and second to fourth digit ratio in school-aged children in the Hokkaido Study.
Steroids, 2019;141:55-62. [5y-IF: 2.505]

2019-25.

Osawa T, Takeuchi A, Kojima T, Shinohara N, Eto M, Nishiyama H.
Overview of current and future systemic therapy for metastatic renal cell carcinoma.
Jpn J Clin Oncol. 2019; doi: 10.1093/jjco/hyz013. [5y-IF: 2.135]

2019-26.

Osawa T, Wei JT, Abe T, Kako Y, Murai S, Shinohara N.
Development of the Japanese version of the health-related quality of life questionnaire for bladder cancer patients using the Bladder Cancer Index: A pilot study.
Int J Urol. 2019; doi: 10.1111/iju.14073. [5y-IF: 2.034]

2019-27.

Ouchi M, Kitta T, Suzuki S, Shinohara N, Kato K.
Evaluating pelvic floor muscle contractility using two-dimensional transperineal ultrasonography in patients with pelvic organ prolapse.
Neurourol Urodyn. 2019. doi: 10.1002/nau.23987. [5y-IF: 2.59]

2019-28.

Ouchi M, Kitta T, Kanno Y, Higuchi M, Togo M, Takahashi Y, Moriya K, Shinohara N.
Dopaminergic urethral closure mechanisms in a rat model of Parkinson's disease.
Neurourol Urodyn. 2019; doi: 10.1002/nau.23989. [5y-IF: 2.59]

2019-29.

Oura T, Hotta K, Rosales I, Dehnadi A, Kawai K, Lee H, Benedict Cosimi A, Kawai T.
Addition of anti-CD40 monoclonal antibody to nonmyeloablative conditioning with belatacept abrogated allograft tolerance despite induction of mixed chimerism.
Transplantation. 2019; 103(1):168-176. [5y-IF: 4.123]

2019-30.

Sekizaki T, Kameda H, Oba C, Yong Cho K, Nakamura A, Miyoshi H, Osawa T, Shinohara N, Atsumi T.
Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation.
Endocr J. 2019; doi: 10.1507/endocrj.EJ19-0076. [5y-IF: 1.907]

2019-31.

Tanaka N, Yamamoto M, Abe T, Osawa T, Matsumoto R, Shinohara N, Saito H, Uchida Y, Morimoto Y.
Changes of cerebral blood volume during robot-assisted laparoscopic radical prostatectomy: observational prospective study using near infrared time-resolved spectroscopy.
J Endourol. 2019; doi: 10.1089/end.2019.0217. [5y-IF: 2.067]

2019-32.

Tanikawa S, Tanino M, Wang L, Ishikawa M, Miyazaki M, Tsuda M, Orba Y, Sawa H, Matoba K, Nakamura N, Nagashima K, Hall WW, Tanaka S.
Autopsy findings in the early stage of amyotrophic lateral sclerosis with "dropped head" syndrome.
Neuropathology 2019; doi: 10.1111/neup.12583. [5y-IF: 1.858]

2019-33.

Thaiss CC, Oura T, Sasaki H, Dehnadi A, Matsunami M, Rosales IA, Cosimi AB, Kawai T.
Importance of Hematopoietic Mixed Chimerism for Induction of Renal Allograft Tolerance in Nonhuman Primates.
Transplantation. 2019; 103(4):689-697. [5y-IF: 4.123]

2019-34.

Tomita Y, Fukasawa S, Shinohara N, Kitamura H, Oya M, Eto M, Tanabe K, Saito M, Kimura G, Yonese J, Yao M, Uemura H.
Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study.
Jpn J Clin Oncol. 2019; doi: 10.1093/jjco/hyz026. [5y-IF: 2.135]

2019-35.

Tomita Y, Uemura H, Oya M, Shinohara N, Habuchi T, Fujii Y, Kamei Y, Umeyama Y, Bair AH, Rini BI.
Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study.
BMC Cancer.;19(1):17[5y-IF: 3.424]

2019-36.

Yagisawa T, Mieno M, Ichimaru N, Morita K, Nakamura M, Hotta K, Kenmochi T, Yuzawa K.
Trens of kidney transplantation in Japan in 2018: data from the kidney transplant registry.
Renal Replacement Therapy. 2019; 5:(3) [5y-IF: ‐　]

2019-37.

Yoshida K, Tsuda M, Matsumoto R, Semba S, Wang L, Sugino H, Tanino M, Kondo T, Tanabe K, Tanaka S.
Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.
Cancer Sci. 2019 110(7):2119-2132. [5y-IF: 4.382]